Document is current
Any future updates will be listed below
-
Authors
Kaufman, Rebecca https://orcid.org/0000-0001-8535-9730
Flores, Guillermo
Boguslawski, Elissa A. https://orcid.org/0000-0003-4233-903X
Kinn-Gurzo, Seneca
Chassé, Maggie
Beddows, Ian https://orcid.org/0000-0001-7403-0016
Adams, Marie https://orcid.org/0000-0001-7909-2339
Stout, Matthew C.
Gaetano, Lauren
Lopez, Raphael
Veluvolu, Sridhar
Fuller, Andrew https://orcid.org/0009-0006-5803-3595
Kitchen-Goosen, Susan M.
Tolstyka, Zachary P.
Gedminas, Jenna M.
Grohar, Patrick J. https://orcid.org/0000-0002-1071-4563
-
Funding
Funding for this research was provided by:
Hyundai Motor Group | Hyundai Motor America | Hyundai Hope On Wheels
Alex's Lemonade Stand Foundation for Childhood Cancer
U.S. Department of Health & Human Services | NIH | National Cancer Institute (F31CA236300)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (F99CA253749)
Gold in September (G9) Foundation
- License Information
-
More Information
Article History
Received: 11 February 2025
Accepted: 30 January 2026
First Online: 16 February 2026
Competing interests
: P.J.G. is a consultant for OrphAI Therapeutics. P.J.G., M.H.C. and E.A.B. have a patent for the method of use of mithramycin for solid tumors characterized by mutant SWI/SNF which is not relevant. P.J.G. receives grant support from Janssen Pharmaceutical and in the last three years served on the Ad Board of Jazz Pharmaceutical. S.S.K.G. has stock in Panosome. The remaining authors have no competing interests.
: The authors declare that no artificial intelligence or AI-assisted technologies were used to formulate, conceive, write or present the above manuscript.
